Who Paid My Doc
Oxycodone hydrochloride
Drug Psychiatry/Psychology
NDC 0054-0390-41
General payments
$1,248,969
Research payments
$672,538
Through program year 2025, $1,248,969 in general payments and $672,538 in research payments were reported against Oxycodone hydrochloride (Psychiatry/Psychology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $239,443 | 3 |
| 2024 | Research | $418,520 | 8 |
| 2023 | Research | $13,075 | 9 |
| 2022 | General | $20,838 | 12 |
| 2021 | General | $692,185 | 14 |
| 2021 | Research | $1,500 | 3 |
| 2020 | General | $535,946 | 14 |
Breakdown
Each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2020 where a state was reported.
Records
40 general · 23 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.